Exploiting reductive evolution in Mycobacterium ulcerans to develop a single-dose cure for Buruli ulcer
Summary Mycobacteria form one of the most successful human pathogens, with Mycobacterium tuberculosis causing tuberculosis and Mycobacterium leprae causing leprosy. Following the effective implementation of the BCG vaccine and the rigorous and conscious effort taken globally to curb tuberculosis an...
Main Author: | Sangeeta, Susan Thomas |
---|---|
Other Authors: | Kevin Pethe |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/152336 |
Similar Items
-
Toward a single-dose cure for buruli ulcer
by: Thomas, Sangeeta Susan, et al.
Published: (2021) -
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
by: Chauffour, Aurélie, et al.
Published: (2021) -
Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?
by: Muhi, S, et al.
Published: (2025) -
Multiple introductions and recent spread of the emerging human pathogen Mycobacterium ulcerans across Africa
by: Vandelannoote, K, et al.
Published: (2017) -
Sensitivity of mycobacterium leprae to telacebec
by: Lahiri, Ramanuj, et al.
Published: (2022)